Sarı, MesutÖzcan, Güler Gölİmrek, Yasemin AkkuşÖztürk, YusufTufan, Ali Evren2024-09-252024-09-2520222687-3532https://doi.org/10.4274/tjcamh.galenos.2020.94830https://search.trdizin.gov.tr/tr/yayin/detay/520202https://hdl.handle.net/20.500.12491/12907Attention deficit hyperactivity disorder (ADHD) is one of the most common neurodevelopmental disorders in children and adolescents and its main symptoms are attention deficit, hyperactivity and impulsivity. Atomoxetine is a selective noradrenaline reuptake inhibitor with proven efficacy in the treatment of ADHD. Although it is known that it has side effects such as gastrointestinal problems, sleep problems, irritability and fatigue, atomoxetine is frequently preferred in children and adolescents with ADHD who also have tic disorder. However, a small number of patients whose tics started or worsened during atomoxetine treatment have been reported. In this case report, we discussed the mechanism of this adverse effect in a 7-year-old child who used atomoxetine for ADHD treatment who had treatment related triggering of tics. © Telif Hakkı 2022 Türkiye Çocuk ve Genç Psikiyatrisi Derneği/Çocuk ve Gençlik Ruh Sağlığı Dergisi, Galenos Yayınevi tarafından yayınlanmıştır.trinfo:eu-repo/semantics/openAccessADHDatomoxetineticArticle10.4274/tjcamh.galenos.2020.9483029147492-s2.0-85185695929N/A520202